Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...
The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US regulator ...
Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. Select will update as changes are made public. Some ...
CHILLICOTHE, Ohio — The Pixelle paper mill in Chillicothe announced it will close down as part of plans to strengthen operations at its other locations. Pixelle is working with employees for a smooth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback